Bicara Therapeutics Inc. · NASDAQ:BCAX
Cohlhepp Ryan sold 12,500 Bicara Therapeutics Inc. shares (Form 4)
Traded Apr 15, 2026 · Filed Apr 17, 2026
On Apr 15, 2026, Cohlhepp Ryan (Director, President and COO) sold 12,500 Bicara Therapeutics Inc. shares at US$23.01 for US$288K under a trading plan, leaving 196,141 shares. Filed Apr 17, 2026 (Form 4).
- Sold
- 12,500 shares
- Price
- US$23.01
- Value
- US$288K
- Holding after
- 196,141 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President and COO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 15, 2026 | Common Stock | Option exercise | 8,000 | US$3.79 | 208,641 | Direct |
| Apr 15, 2026 | Common Stock | Sale | 8,000 | US$23.01 | 200,641 | Direct |
| Apr 15, 2026 | Common Stock | Sale | 4,500 | US$23.01 | 196,141 | Direct |
Source
Related
- Bicara Therapeutics Inc.
- Cohlhepp Ryan
- Bicara Therapeutics Inc. shareholders
- Form 4 · Cohlhepp Ryan · Sep 10, 2026
- Form 4 · Cohlhepp Ryan · Aug 12, 2026
- Form 4 · Cohlhepp Ryan · Jul 10, 2026
- Form 4 · Cohlhepp Ryan · May 18, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Oct 7, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Hyep Ivan · Aug 12, 2026
- Form 4 · Mazumdar Claire · Aug 12, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026